BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 9512543)

  • 1. The processivity of DNA synthesis exhibited by drug-resistant variants of human immunodeficiency virus type-1 reverse transcriptase.
    Avidan O; Hizi A
    Nucleic Acids Res; 1998 Apr; 26(7):1713-7. PubMed ID: 9512543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New human immunodeficiency virus, type 1 reverse transcriptase (HIV-1 RT) mutants with increased fidelity of DNA synthesis. Accuracy, template binding, and processivity.
    Kim B; Ayran JC; Sagar SG; Adman ET; Fuller SM; Tran NH; Horrigan J
    J Biol Chem; 1999 Sep; 274(39):27666-73. PubMed ID: 10488107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of increased processivity on overall fidelity of human immunodeficiency virus type 1 reverse transcriptase.
    Rezende LF; Kew Y; Prasad VR
    J Biomed Sci; 2001; 8(2):197-205. PubMed ID: 11287751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fidelity of misinsertion and mispair extension throughout DNA synthesis exhibited by mutants of the reverse transcriptase of human immunodeficiency virus type 2 resistant to nucleoside analogs.
    Taube R; Avidan O; Hizi A
    Eur J Biochem; 1997 Nov; 250(1):106-14. PubMed ID: 9431997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominance of the E89G substitution in HIV-1 reverse transcriptase in regard to increased polymerase processivity and patterns of pausing.
    Quan Y; Inouye P; Liang C; Rong L; Götte M; Wainberg MA
    J Biol Chem; 1998 Aug; 273(34):21918-25. PubMed ID: 9705331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased processivity of human immunodeficiency virus type 1 reverse transcriptase (RT) containing didanosine-selected mutation Leu74Val: a comparative analysis of RT variants Leu74Val and lamivudine-selected Met184Val.
    Sharma PL; Crumpacker CS
    J Virol; 1999 Oct; 73(10):8448-56. PubMed ID: 10482597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased drug susceptibility of HIV-1 reverse transcriptase mutants containing M184V and zidovudine-associated mutations: analysis of enzyme processivity, chain-terminator removal and viral replication.
    Naeger LK; Margot NA; Miller MD
    Antivir Ther; 2001 Jun; 6(2):115-26. PubMed ID: 11491416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the Delta67 complex of mutations in human immunodeficiency virus type 1 reverse transcriptase on nucleoside analog excision.
    Boyer PL; Imamichi T; Sarafianos SG; Arnold E; Hughes SH
    J Virol; 2004 Sep; 78(18):9987-97. PubMed ID: 15331732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic mechanism of HIV-1 resistance to 3'-azido-3'-deoxythymidine (AZT): increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase.
    Arion D; Kaushik N; McCormick S; Borkow G; Parniak MA
    Biochemistry; 1998 Nov; 37(45):15908-17. PubMed ID: 9843396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fidelity of 3' misinsertion and mispair extension during DNA synthesis exhibited by two drug-resistant mutants of the reverse transcriptase of human immunodeficiency virus type 1 with Leu74-->Val and Glu89-->Gly.
    Rubinek T; Bakhanashvili M; Taube R; Avidan O; Hizi A
    Eur J Biochem; 1997 Jul; 247(1):238-47. PubMed ID: 9249032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nucleoside analogs 4'C-methyl thymidine and 4'C-ethyl thymidine block DNA synthesis by wild-type HIV-1 RT and excision proficient NRTI resistant RT variants.
    Boyer PL; Julias JG; Ambrose Z; Siddiqui MA; Marquez VE; Hughes SH
    J Mol Biol; 2007 Aug; 371(4):873-82. PubMed ID: 17597154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased polymerase fidelity of lamivudine-resistant HIV-1 variants does not limit their evolutionary potential.
    Keulen W; van Wijk A; Schuurman R; Berkhout B; Boucher CA
    AIDS; 1999 Jul; 13(11):1343-9. PubMed ID: 10449287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of mutations at positions 115 and 116 in the dNTP binding site of HIV-1 reverse transcriptase.
    Boyer PL; Sarafianos SG; Arnold E; Hughes SH
    Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3056-61. PubMed ID: 10737786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based design of non-nucleoside reverse transcriptase inhibitors of drug-resistant human immunodeficiency virus.
    Mao C; Sudbeck EA; Venkatachalam TK; Uckun FM
    Antivir Chem Chemother; 1999 Sep; 10(5):233-40. PubMed ID: 10574178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymatic properties of two mutants of reverse transcriptase of human immunodeficiency virus type 1 (tyrosine 181-->isoleucine and tyrosine 188-->leucine), resistant to nonnucleoside inhibitors.
    Loya S; Bakhanashvili M; Tal R; Hughes SH; Boyer PL; Hizi A
    AIDS Res Hum Retroviruses; 1994 Aug; 10(8):939-46. PubMed ID: 7529032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased polymerase fidelity of the 3TC-resistant variants of HIV-1 reverse transcriptase.
    Oude Essink BB; Back NK; Berkhout B
    Nucleic Acids Res; 1997 Aug; 25(16):3212-7. PubMed ID: 9241233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of polymerase activity due to Tyr to Phe substitution in the YMDD motif of human immunodeficiency virus type-1 reverse transcriptase is compensated by Met to Val substitution within the same motif.
    Harris D; Yadav PN; Pandey VN
    Biochemistry; 1998 Jul; 37(27):9630-40. PubMed ID: 9657675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.
    Back NK; Nijhuis M; Keulen W; Boucher CA; Oude Essink BO; van Kuilenburg AB; van Gennip AH; Berkhout B
    EMBO J; 1996 Aug; 15(15):4040-9. PubMed ID: 8670908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus mutagenesis during antiviral therapy: impact of drug-resistant reverse transcriptase and nucleoside and nonnucleoside reverse transcriptase inhibitors on human immunodeficiency virus type 1 mutation frequencies.
    Chen R; Yokoyama M; Sato H; Reilly C; Mansky LM
    J Virol; 2005 Sep; 79(18):12045-57. PubMed ID: 16140780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substitutions at Phe61 in the beta3-beta4 hairpin of HIV-1 reverse transcriptase reveal a role for the Fingers subdomain in strand displacement DNA synthesis.
    Fisher TS; Darden T; Prasad VR
    J Mol Biol; 2003 Jan; 325(3):443-59. PubMed ID: 12498795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.